Cho Sh - Search Results

1

A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer.

Oh SY, Kwon HC, Jeong SH, Joo YT, Lee YJ, Cho Sh, Kang MH, Go SI, Lee GW, Kim Hg, Kang JH. Oh SY, et al. Among authors: cho sh. Invest New Drugs. 2012 Feb;30(1):350-6. doi: 10.1007/s10637-010-9507-2. Epub 2010 Aug 13. Invest New Drugs. 2012. PMID: 20706861 Clinical Trial.

2

A phase II study of irinotecan, continuous 5-fluorouracil, and leucovorin (FOLFIRI) combination chemotherapy for patients with recurrent or metastatic gastric cancer previously treated with a fluoropyrimidine-based regimen.

Kim SH, Lee GW, Go SI, Cho SH, Kim HJ, Kim HG, Kang JH. Kim SH, et al. Among authors: cho sh. Am J Clin Oncol. 2010 Dec;33(6):572-6. doi: 10.1097/COC.0b013e3181bead7b. Am J Clin Oncol. 2010. PMID: 20042971 Clinical Trial.

3

Phase II study of a biweekly schedule of docetaxel and cisplatin in patients with metastatic non-small cell lung cancer.

Cho SH, Go SI, Lee GW, Kang JH, Kim HG, Kim SH, Cho YJ, Jeong YY, Kim HC, Lee JD, Hwang YS. Cho SH, et al. Among authors: cho yj. Lung Cancer. 2010 Jul;69(1):94-8. doi: 10.1016/j.lungcan.2009.09.005. Epub 2009 Sep 30. Lung Cancer. 2010. PMID: 19796840 Clinical Trial.

4

Treatment outcomes between concurrent chemoradiotherapy and combination of surgery, radiotherapy, and/or chemotherapy in stage III and IV maxillary sinus cancer: multi-institutional retrospective analysis.

Kang JH, Cho SH, Kim JP, Kang KM, Cho KS, Kim W, Seol YM, Lee S, Park HS, Hur WJ, Choi YJ, Oh SY. Kang JH, et al. Among authors: cho ks, cho sh. J Oral Maxillofac Surg. 2012 Jul;70(7):1717-23. doi: 10.1016/j.joms.2011.06.221. Epub 2011 Sep 25. J Oral Maxillofac Surg. 2012. PMID: 21945430

5

Statin use has negative clinical impact on non-germinal center in patients with diffuse large B cell lymphoma in rituximab era.

Song MK, Chung JS, Lee GW, Cho SH, Hong J, Shin DY, Shin HJ. Song MK, et al. Among authors: cho sh. Leuk Res. 2015 Feb;39(2):211-5. doi: 10.1016/j.leukres.2014.12.003. Epub 2014 Dec 9. Leuk Res. 2015. PMID: 25541029 Clinical Trial.

6

The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).

Jo JC, Lee HS, Kim K, Lee JJ, Yoon SS, Bang SM, Kim JS, Eom HS, Yoon DH, Lee Y, Shin HJ, Park Y, Lee WS, Do YR, Mun YC, Lee MH, Kim HJ, Kim SH, Kim MK, Lim SN, Cho SH, Park SK, Yi JH, Lee JH, Kim J, Min CK; Korean Multiple Myeloma Working Party (KMMWP). Jo JC, et al. Among authors: cho sh. Ann Hematol. 2020 Feb;99(2):309-319. doi: 10.1007/s00277-019-03904-7. Epub 2019 Dec 23. Ann Hematol. 2020. PMID: 31872360 Clinical Trial.

7

Metabolic response evaluated by 18F-FDG PET/CT as a potential screening tool in identifying a subgroup of patients with advanced non-small cell lung cancer for immediate maintenance therapy after first-line chemotherapy.

Moon SH, Cho SH, Park LC, Ji JH, Sun JM, Ahn JS, Park K, Choi JY, Ahn MJ. Moon SH, et al. Among authors: cho sh. Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1005-13. doi: 10.1007/s00259-013-2400-4. Epub 2013 Apr 18. Eur J Nucl Med Mol Imaging. 2013. PMID: 23595109

8

Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy.

Oh SB, Park SW, Chung JS, Lee WS, Lee HS, Cho SH, Choi YS, Lim SN, Shin HJ; Hematology Association of South-East Korea (HASEK) study group. Oh SB, et al. Among authors: cho sh. Ann Hematol. 2017 Nov;96(11):1801-1809. doi: 10.1007/s00277-017-3104-9. Epub 2017 Aug 21. Ann Hematol. 2017. PMID: 28828639

9

Phase II study of safety and efficacy of BEB (bendamustine, etoposide, and busulfan) conditioning regimen for autologous stem cell transplantation in non-Hodgkin lymphoma.

Kim DY, Chung JS, Jo JC, Cho SH, Shin HJ. Kim DY, et al. Among authors: cho sh. Ann Hematol. 2020 Apr;99(4):819-828. doi: 10.1007/s00277-020-03942-6. Epub 2020 Feb 5. Ann Hematol. 2020. PMID: 32025840 Clinical Trial.

10

Pralatrexate in patients with recurrent or refractory peripheral T-cell lymphomas: a multicenter retrospective analysis.

Hong JY, Yoon DH, Yoon SE, Kim SJ, Lee HS, Eom HS, Lee HW, Shin DY, Koh Y, Yoon SS, Jo JC, Kim JS, Kim SJ, Cho SH, Lee WS, Won JH, Kim WS, Suh C. Hong JY, et al. Among authors: cho sh. Sci Rep. 2019 Dec 30;9(1):20302. doi: 10.1038/s41598-019-56891-0. Sci Rep. 2019. PMID: 31889144 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,356 results

Search Page